Skyward Specialty Insurance Group secures regulatory approval for Apollo acquisition, surpasses EPS estimates, and outlines robust 2026 financial guidance, boosting investor confidence in specialty insurance sector.

Elevance Health lowers 2024 earnings guidance due to rising medical utilization, Medicaid eligibility checks resuming, and regulatory challenges impacting Medicaid and ACA programs.

UnitedHealth Group faces a securities class action lawsuit after slashing 2025 earnings guidance and reporting Q1 losses, raising issues on Medicare Advantage utilization and corporate disclosures.